Idorsia Ltd.’s CHF330 Million Private Placement Of New Shares

Niederer Kraft Frey advised Swiss biopharmaceutical company Idorsia Ltd on the transaction. Idorsia Ltd, a Swiss biopharmaceutical company, successfully completed a private placement with institutional investors…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now